Latest Insights - page 78 | BiopharmaTrend

Bruker Acquires ZONTAL, Boosting Digital Transformation in Pharma Laboratories

The pharmaceutical industry is undergoing a significant shift as digital transformation in pharma continues to reshape the landscape. Bruker Corporation, a leading provider of high-performance scientific instruments and solutions, recently …

Continue ›››

Advancing Cell-free Biocomputing

Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA Universal Multi-Purpose GatE PlaTform (Trumpet), which leverages biological enzymes as …

Continue ›››

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) and quantum computing, to accelerate research in messenger RNA (mRNA) …

Continue ›››

The Power of STB CLOUD in Remote AI Drug Discovery

AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning

The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several years, both in mainstream media and academic press. These new …

Continue ›››

RetinAI and Boehringer Ingelheim Collaborate on AI-Driven Drug Discovery for Geographic Atrophy Treatment

Established in 2017 in Swiss, RetinAI Medical AG is a notable player in clinical and imaging data management software and advanced analytics using artificial intelligence (AI) for ophthalmology, which has …

Continue ›››

Myricx Pharma Showcases Promising Pre-Clinical Data for NMTi ADC Programme at AACR

Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented positive pre-clinical proof of concept data at the American Association …

Continue ›››

Enamine and Endogena's Persistent Collaboration Paves the Way for Regenerative Medicine Advancements

In a world where innovation and collaboration play a critical role in the development of cutting-edge therapies, Enamine Ltd. and Endogena Therapeutics AG have forged a strong partnership to drive …

Continue ›››

Macomics Unveils ENIGMAC™ Discovery Platform at AACR for Target Validation in Macrophage Therapies

Macomics Ltd, a frontrunner in macrophage drug discovery, recently showcased its innovative ENIGMAC™ macrophage drug discovery platform at the American Association for Cancer Research's Annual Meeting (AACR 2023). The company …

Continue ›››

Reimagining Genomics Data Analysis: Interview with Paolo Di Tommaso from Seqera Labs

With BioNTech’s recent $200 million merger with OncoC4’s cancer drug, the demand for personalised medicines to treat diseases such as cancer continues to grow. Much of this development stems from pharmaceutical …

Continue ›››

FDA Collaborates with Cerner Enviza and John Snow Labs to Harness AI and EHR Data Analytics for Pharmacovigilance

Cerner Enviza, an Oracle company, and John Snow Labs have been selected by the FDA's Sentinel Innovation Center to support the Sentinel Initiative, focusing on AI drug discovery and real-world …

Continue ›››

PsychoGenics Introduces eCube, an AI-Driven Platform for Drug Discovery in Neuropsychiatric Disorders

PsychoGenics, a prominent player in AI-enabled phenotypic drug discovery and preclinical CRO services, has recently unveiled eCube, an innovative pharmaco-electroencephalography (pharmacoEEG) platform designed to enhance phenotypic drug discovery. By employing …

Continue ›››